Jagsonpal Pharmaceuticals Limited has made a regulatory disclosure pursuant to Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, read with Part A of Schedule III thereto. The disclosure concerns the designation of two individuals as Senior Management Personnel of the Company effective July 29, 2026, consequent to internal restructuring.

Appointments Effective

  • Effective Date: July 29, 2026

Designated Senior Management Personnel

1. Mr. Balmukund Keshav designated as Deputy General Manager (Information Technology)

2. Mr. Sanjay Singhal designated as General Manager (CQA & Regulatory Affairs)

Reason for Change

Both designations are categorized as "Designated as Senior Management Personnel" due to internal restructuring.

Term of Appointment

For both individuals, the term of appointment is stated as "Not Applicable."

Brief Profiles

Mr. Balmukund Keshav (DGM - IT)

  • Educational Qualifications: MBA in Information Systems from Sikkim Manipal University and B.Sc. (Chemistry Hons.) from Magadh University
  • Experience: Over 29 years of experience in IT leadership
  • Tenure with Company: 17 years with Jagsonpal Pharmaceuticals Ltd
  • Current Role: Deputy General Manager – IT
  • Expertise: Digital transformation, ERP implementation, ITGC audits, enterprise infrastructure management, IT governance, risk and information security, vendor management, and digital process automation

Mr. Sanjay Singhal (GM - CQA & Regulatory Affairs)

  • Educational Qualifications: Masters Degree in Pharmaceutical science from Birla Institute of Technical studies, Pilani (BITS PILANI)
  • Experience: 31 years' experience in pharmaceutical industry
  • Tenure with Company: Associated since March 11, 2020
  • Expertise: Comprehensive expertise across all pharmaceutical divisions including manufacturing, supply chain, Quality and regulatory affairs
  • Additional Role: Government approved technical person for all dosage forms across manufacturing and analytical divisions

Relationships Disclosure

Not Applicable - The disclosure specifically notes that information about relationships between directors is not applicable for these appointments.

Additional Exchange Circular Compliance

Not Applicable - The disclosure notes that information required pursuant to BSE Circular LIST/COMP/14/2018-19 and NSE Circular NSE/CML/2018/24, both dated June 20, 2018, is not applicable.